|
| Press Releases |
|
 |
|
| Thursday, November 14, 2024 |
|
|
Blueberry Rebrand Reflects Exciting New Era for the Forex Company |
| Blueberry, a leading global forex broker, is excited to announce a significant rebrand for the company, which sees the company's name changing from Blueberry Markets to Blueberry, alongside a new sophisticated look and feel. more info >> |
|
|
Blueberry Rebrand Reflects Exciting New Era for the Forex Company |
| Blueberry, a leading global forex broker, is excited to announce a significant rebrand for the company, which sees the company's name changing from Blueberry Markets to Blueberry, alongside a new sophisticated look and feel. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Icarus' Future: A Miami-Born Campaign Telling COP30 Leaders Our Children's Future is at Stake - Just Won Seven LUUM Awards
Nov 18, 2025 08:00 HKT/SGT
|
|
|
Radisson Announces Exercise of Warrants
Nov 18, 2025 06:29 HKT/SGT
|
|
|
Mazda Begins Demonstration Experiment of Onboard CO2 Capture System
Nov 17, 2025 0:38 JST
|
|
|
Pushing Hydrogen Engine Technology to New Heights in the Super Taikyu Series Final Race
Nov 17, 2025 0:00 JST
|
|
|
Graid Technology 完成與英特爾 VROC 的授權協議，拓展其在企業儲存解決方案領域的領導地位
Nov 17, 2025 23:00 HKT/SGT
|
|
|
OBI-902、米国FDAより胆管癌治療を対象とした希少疾病用医薬品指定を取得
Nov 17, 2025 23:00: JST
|
|
|
Fujitsu launches business creation lab in collaboration with AWS Japan
Nov 17, 2025 23:41 JST
|
|
|
NTT DOCOMO Achieves Successful Outdoor Trial of AI-Driven Wireless Interface Toward 6G
Nov 17, 2025 23:05 JST
|
|
|
Graid Technology Finalizes Intel VROC Licensing Agreement, Expanding Leadership in Enterprise Storage Solutions
Nov 17, 2025 22:00 HKT/SGT
|
|
|
JBM Healthcare Announces FY2026 Interim Results
Nov 17, 2025 21:43 HKT/SGT
|
|
|
健倍苗苗公佈二零二六財政年度中期業績
Nov 17, 2025 21:43 HKT/SGT
|
|
|
健倍苗苗公布二零二六财政年度中期业绩
Nov 17, 2025 21:43 HKT/SGT
|
|
|
Destinator Earns the Highest Rating of Five Stars in 2025 ASEAN NCAP
Nov 17, 2025 22:32 JST
|
|
|
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in the United Kingdom
Nov 17, 2025 22:08 JST
|
|
|
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Nov 17, 2025 21:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
